Takotsubo cardiomyopathy in a patient with essential thrombocythemia treated with anagrelide: Case report

We reported rare case of takotsubo cardiomyopathy caused by high dose anagrelide therapy. Anagrelide is the most often used in patients with thrombocythemia. It belongs to phosphodiesterase III inhibitors and through specific pathways has certain effects on myocardium. It is the first case of takotsubo cardiomyopathy resulting from anagrelide therapy in the Czech Republic.
Source: Cor et Vasa - Category: Cardiology Source Type: research